Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers

by Nicolas Jacquelot, Nicolas Jacquelot, Connie P. M. Duong, Connie P. M. Duong, Gabrielle T. Belz, Gabrielle T. Belz, Laurence Zitvogel, Laurence Zitvogel, Laurence Zitvogel, Laurence Zitvogel
Published 2018-10-01

Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?

by Lisa Derosa, Laurence Zitvogel
Published 2021-05-01

Cross-reactivity between cancer and microbial antigens

by Laurence Zitvogel, Guido Kroemer
Published 2021-01-01

Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade

by Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Published 2019-10-01

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer

by Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Published 2020-01-01

Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’

by Nicolas Jacquelot, Laurence Zitvogel, Alexander M. Eggermont
Published 2018-07-01

Failure of immunosurveillance accelerates aging

by Maria Perez-Lanzon, Laurence Zitvogel, Guido Kroemer
Published 2019-04-01

The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

by Lisa Derosa, Bertrand Routy, Guido Kroemer, Laurence Zitvogel
Published 2018-06-01

COVID-19: a challenge for oncology services

by Bertrand Routy, Lisa Derosa, Laurence Zitvogel, Guido Kroemer
Published 2020-01-01

Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota

by Marine Fidelle, Marine Fidelle, Marine Fidelle, Marine Fidelle, Marine Fidelle, Satoru Yonekura, Satoru Yonekura, Satoru Yonekura, Satoru Yonekura, Marion Picard, Marion Picard, Marion Picard, Marion Picard, Alexandria Cogdill, Alexandria Cogdill, Antoine Hollebecque, Antoine Hollebecque, Maria Paula Roberti, Maria Paula Roberti, Maria Paula Roberti, Laurence Zitvogel, Laurence Zitvogel, Laurence Zitvogel, Laurence Zitvogel, Laurence Zitvogel
Published 2020-12-01

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?

by Maria Paula Roberti, Marion Picard, Satoru Yonekura, Laurence Zitvogel
Published 2020-01-01

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

by Gautier Stoll, Jonathan Pol, Vassili Soumelis, Laurence Zitvogel, Guido Kroemer
Published 2018-10-01

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

by David P. Enot, Erika Vacchelli, Nicolas Jacquelot, Laurence Zitvogel, Guido Kroemer
Published 2018-09-01

Trial watch: STING agonists in cancer therapy

by Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, Erika Vacchelli, Guido Kroemer
Published 2020-01-01

Trial watch: TLR3 agonists in cancer therapy

by Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Erika Vacchelli
Published 2020-01-01

Trial watch: IDO inhibitors in cancer therapy

by Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Erika Vacchelli
Published 2020-01-01

Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications

by Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell, Lorenzo Galluzzi
Published 2017-12-01

Pro-necrotic molecules impact local immunosurveillance in human breast cancer

by Gautier Stoll, Yuting Ma, Heng Yang, Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Published 2017-04-01

Trial Watch: Adoptively transferred cells for anticancer immunotherapy

by Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Lionel Apetoh
Published 2017-11-01

Trial watch: dietary interventions for cancer therapy

by Sarah Lévesque, Jonathan G. Pol, Gladys Ferrere, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer
Published 2019-07-01